https://www.selleckchem.com/pr....oducts/actinomycin-d
For instance, a woman at an institution with low-risk of performing cALND would have 74% reduced odds of having a cALND than if she was treated at a median-risk institution, while a patient at a high-risk institution had 3.91 times the odds. Compared to known patient, tumor and institutional factors, contextual effects had a higher contribution to the variation in cALND use. Compared to known patient, tumor and institutional factors, contextual effects had a higher contribution to the variation in cALND use. To explore the impact
Aimer
Commentaire
Partagez
